Finanzwire Finanzwire
Basculer en Français
10467 Companies
220283 Keywords
149614 Articles
116473 Press releases
Headlines Articles Press releases The Lifesciences Magazine Remove
  1. Home
  2. Companies
  3. The Lifesciences Magazine
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 07/05/2024 at 14:05, 1 year 10 months ago

    The Lifesciences Magazine Highlights Innovative Biopharma Company Targeting Diabetes in 2024

    Innovation Diabetes Healthcare Treatment Biopharma
  • PRESS RELEASE

    published on 07/05/2024 at 14:00, 1 year 10 months ago

    The Lifesciences Magazine's New Issue Features the Most Innovative Biopharma Company Targeting Diabetes in 2024

    Lifesciences Magazine features Diabetology Limited, a leading biopharma company revolutionizing diabetes treatment. Exclusive interview with co-founder Glen Travers
    Innovation Diabetes Treatment Biopharma Lifesciences Magazine Diabetology Limited
    Logo of The Lifesciences Magazine
Accesswire
  • Published on 05/28/2026 at 19:20, 3 hours 6 minutes ago

    Lithium South Announces Filing of Audited Financial Statements, Receipt of Revocation Order, Closing of Plan of Arrangement and Delisting from TSX Venture Exchange

  • Published on 05/28/2026 at 18:10, 4 hours 16 minutes ago

    GGL Resources Corp. Announces Receipt of Upfront Cash Payment and Shares from Nelson Resources Limited and Adoption of Semi-Annual Reporting

  • Published on 05/28/2026 at 17:45, 4 hours 41 minutes ago

    Sky Gold Completes Drilling Program

  • Published on 05/28/2026 at 16:00, 6 hours 26 minutes ago

    Exercise of Options

  • Published on 05/28/2026 at 16:00, 6 hours 26 minutes ago

    Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders

View all ACCESSWIRE
EQS Group
  • Published on 05/28/2026 at 22:15, 11 minutes ago

    Nebius to present at BofA Global Technology conference

  • Published on 05/28/2026 at 19:23, 3 hours 2 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 05/28/2026 at 18:55, 3 hours 30 minutes ago

    HOL-Holding(s) in Company

  • Published on 05/28/2026 at 18:50, 3 hours 35 minutes ago

    Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

  • Published on 05/28/2026 at 18:40, 3 hours 45 minutes ago

    Following Sanctions-Risk Information from Western Partners, the Ministry of Justice of the Kyrgyz Republic Suspends 50 Legal Entities in First-Ever Use of Interagency Law to Crack Down on Malign Foreign Economic Activity

View all EQS
Les Echos
  • Published on 05/28/2026 at 18:34, 3 hours 51 minutes ago

    LNA SANTE : Expanding hospital at home in Ile-de-France region

  • Published on 05/28/2026 at 18:06, 4 hours 19 minutes ago

    Net profit and EBITDA up driven by the recovery in volumes and improvement in unit margins in the Recycling business. Upgrade in outlook

  • Published on 05/28/2026 at 18:00, 4 hours 26 minutes ago

    Revenues for fiscal year 2025/2026

  • Published on 05/28/2026 at 17:50, 4 hours 36 minutes ago

    Press release relating to the availability of the preparatory documents – GM of 18 June 2026

  • Published on 05/28/2026 at 17:45, 4 hours 41 minutes ago

    EURAZEO ACQUIRES T1A GROUP IN DENMARK TO ACCELERATE THE CIRCULAR ECONOMY IN THE IT SECTOR

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy